about
Development of biomarkers to optimize pediatric patient management: what makes children different?A novel knowledge representation framework for the statistical validation of quantitative imaging biomarkersStructure-function correlation of the human central retinaAssessment of estimated retinal atrophy progression in Stargardt macular dystrophy using spectral-domain optical coherence tomographyMammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapiesPotential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference.Acute Stroke Imaging Research Roadmap II.Epilepsy biomarkers.Biological markers in noninvasive brain stimulation trials in major depressive disorder: a systematic review.Is the quality of data in an electronic medical record sufficient for assessing the quality of primary care?Use of High-Frequency In-Home Monitoring Data May Reduce Sample Sizes Needed in Clinical Trials.Diagnostic imaging devices in Alzheimer's disease.Validating a proxy for disease progression in metastatic cancer patients using prescribing and dispensing data.Current and future uses of neuroimaging for cognitively impaired patients.Carotid ultrasonography: A potent tool for better clinical practice in diagnosis of atherosclerosis in diabetic patients.Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects.The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical ResearchAlzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible.Controversies in Alzheimer's disease drug developmentEarly change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysisGuidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design.Central nervous system drug development: an integrative biomarker approach toward individualized medicine.The application of biomarkers in clinical trials for motor neuron diseaseIntegrating ADNI results into Alzheimer's disease drug development programs.Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.Con: Can biomarkers be gold standards in Alzheimer's disease?Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shiftGuide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants.Methods and challenges in quantitative imaging biomarker developmentQuantifying disease progression in amyotrophic lateral sclerosis.Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease.Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the futureBiological markers for early detection and pharmacological treatment of Alzheimer's disease.A pathway and approach to biomarker validation and qualification for osteoarthritis clinical trials.Application of biomarkers to clinical trials in systemic sclerosis.Current state of the art for enhancing urine biomarker discovery.Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.The ultimate model organism: progress in experimental medicine.ALS biomarkers for therapy development: State of the field and future directions.Biomarkers for amyotrophic lateral sclerosis.
P2860
Q26822946-F8ACB96D-FD37-412F-BB87-808D3A1B601EQ26825076-35D643E4-FCB3-44B5-8F90-28AD860391C4Q27319838-0F438B53-429A-4B14-ACFA-BEEE0AA48C51Q27320223-B7C5601D-9DF0-4266-83CF-06ACCD4353E4Q28074177-E466FD7C-E676-4D54-88B2-9DA688209CF9Q30410183-A0A7B0BF-FAB0-4D92-8183-92EA2E63151DQ30411115-9F038458-A1F8-4DDA-89C9-6996CBDE6D8AQ30411290-D98996A6-ECC9-455B-B7B8-AB2284770425Q30654701-9FC798C0-091A-45C6-AB21-F108BD93E8EDQ30681480-2D9808B7-7C63-4B1E-938F-D34BDB365E62Q30994007-8D52B471-0B85-41DB-97DB-24E58FBAF279Q31117394-02277171-D6E8-4425-A8C4-7B64CE927853Q31132965-F172DD44-3AAB-4500-A403-B8E33B79B4ADQ31143267-9833B57E-9D9F-4885-B8DB-C76E69EBB56DQ33628605-8EB98963-F740-462F-8803-4A1C475ABD24Q33691896-7F79FB96-D6F6-4010-82DF-59D2D1428EA0Q33756582-5DB5D627-95F5-4AAA-BEF3-69838F931AD3Q33773031-65293716-9643-4965-9597-B76326BE5917Q33805090-5D5D6C13-3B87-45B9-A7EB-7D0B9CE0D5F0Q33805412-2808E7D5-5C29-460E-BDD3-27188C8BCFB0Q33932859-65E7D27E-3CC2-4FF2-9035-C61A6DC4DF69Q33947007-E5D84CC0-A4AE-420F-96E1-FFCAF07F2F5EQ33961751-4EDD2E43-5CD4-4F3D-9B41-B7FA3E01A932Q33987409-29ABC7BA-FEE3-4591-9790-0AC48BD01B74Q34039983-1B7110E4-A1CF-4B32-B48A-875D063D5470Q34058287-09A77E9B-5D45-488A-A03D-D1DCB16AAB4FQ34160589-3DF14283-B098-47CD-BF25-E16A3287CA8FQ34165056-5E993E83-9D19-48B1-A651-9A710793FE17Q34648114-5D23CC55-6AED-43F5-9CFE-C6B871B3C797Q35008605-FB435899-8DAB-4B6D-924E-8F40CC7FB558Q35042489-F800F18D-7AD8-4FBF-B8ED-3CAD3BBA5601Q35078327-D0AA8842-0217-4783-801E-3183B16FBE08Q35237100-FD393F7E-E433-441B-9585-6C9D22CFBF9FQ35681400-9E6F151F-DB06-49DD-9B94-D71098939003Q35681874-A679F44B-323C-4387-BC78-E6DD712A162BQ36032361-C2E48988-B22A-4C2B-A66A-AB37B6BCDBCBQ36161527-86265CA1-9743-459B-9313-D71391FD4FDBQ36213997-43C0B742-DDB0-4593-99B2-DD376946ABE5Q36479616-AFD94FE4-C854-48DD-9743-DCD8BCE626E6Q36481118-E4B400B2-7F7E-4AEF-B44B-94C85F67BB03
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Biomarkers and surrogate markers: an FDA perspective.
@ast
Biomarkers and surrogate markers: an FDA perspective.
@en
type
label
Biomarkers and surrogate markers: an FDA perspective.
@ast
Biomarkers and surrogate markers: an FDA perspective.
@en
prefLabel
Biomarkers and surrogate markers: an FDA perspective.
@ast
Biomarkers and surrogate markers: an FDA perspective.
@en
P2860
P356
P1433
P1476
Biomarkers and surrogate markers: an FDA perspective.
@en
P2093
Russell Katz
P2860
P304
P356
10.1602/NEURORX.1.2.189
P577
2004-04-01T00:00:00Z